Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke

American Journal of Hematology

Volumn 88, Issue 3, 2013, Pages 237-239

  Idowu, Modupe ^a   Reddy, Preethi ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; PHENYTOIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANTICONVULSANT THERAPY; APHASIA; ARM WEAKNESS; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; DYSARTHRIA; FAMILY HISTORY; FEMALE; FIBRINOLYTIC THERAPY; HEMIPARESIS; HUMAN; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEIZURE; THROMBECTOMY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; STROKE;

EID: 84874307330     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23249     Document Type: Article

References (22)

1. Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: The role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 2001;14:437-454.
2. Zheng L, Kaufman R, Goodnough L, et al. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004;103:4043-4049.
3. Porta C, Caporali R, Montecucco C. Thrombotic thrombocytopenic purpura and autoimmunity: A tale of shadows and suspects. Haematologica 1999;84:260-269.
4. Leaf AN, Laubenstein LJ, Raphael B, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988;109:194-197.
5. May HVJr, Harbert GMJr, Thornton WNJr. Thrombotic thrombocytopenic purpura associated with pregnancy. Am J Obstet Gynecol 1976;126:452-458.
6. Elliott MA, Nichols WLJr, Plumhoff EA, et al. Posttransplantation thrombotic thrombocytopenic purpura: A single-center experience and a contemporary review. Mayo Clin Proc 2003;78:421-430.
7. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura hemolytic uremic syndrome. Curr Opin Hematol 2001;8:286-293.
8. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-4234.
9. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996;87:4235-4244.
10. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute TTP. N Engl J Med 1998;339:1585-1594.
11. Rieger M, Manuccio PM, Kremer Hovinga JA, et al. ADAMTS 13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 2005;106:1262-1267.
12. Vesely SK, George IN, Lammle B, et al. ADAMTS 13 activity in TTP-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-68.
13. Kremer Hovinga JA, Vesely SK, Terrell DR, et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-1511.
14. Amorosi EL, Ultmann JE. Thrombocytopic purpura: Report of 16 cases and review of the literature. Medicine (Baltimore) 1966;45:139-159.
15. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
16. Downes KA, Yomtovian R, Tsai HM, et al. Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. J Clin Apher 2004;19:86-89.
17. Sarode R. Atypical presentation of thrombotic thrombocytopenic purpura: A review. J Clin Apheresis 2009;24:47-52.
18. Tsai HM, Shulman K. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 2003;70:183-185.
19. O'Brien TE, Crum ED. Atypical presentations of thrombotic thrombocytopenic purpura. Int J Hematol 2002;76:471-473.
20. Tao A, Anthony K, Peng Y, et al. Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. J Thromb Haemost 2006;4:1931-1935.
21. Burrus TM, Wijdicks EF, Rabinstein AA. Brains lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology 2009;73:66-70.
22. Aksay E, Kiyan S, Ersel M, et al. Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke. Emerg Med J 2006;23:e51.